Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma

BACKGROUND: Hepatoma arterial-embolization prognostic (HAP) score and its modifications (modified HAP [mHAP] and mHAP-II), consisting of some or all of the following factors of tumor size, number, alpha-fetoprotein, bilirubin, and serum albumin, have been found to predict outcomes after trans-arteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Yehyun, Kim, Beom Kyung, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Han, Kwang-Hyub, Yeon, Jong Eun, Byun, Kwan Soo, Kim, Hye Soo, Kim, Ji Hoon, Kim, Seung Up
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469056/
https://www.ncbi.nlm.nih.gov/pubmed/30991968
http://dx.doi.org/10.1186/s12885-019-5495-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469056/
https://www.ncbi.nlm.nih.gov/pubmed/30991968
http://dx.doi.org/10.1186/s12885-019-5495-6

Ejemplares similares